TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
129.61
-10.46 (-7.47%)
At close: Mar 6, 2026, 4:00 PM EST
129.50
-0.11 (-0.08%)
After-hours: Mar 6, 2026, 7:58 PM EST
TransMedics Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 605.49 | 441.54 | 241.62 | 93.46 | 30.26 | Upgrade
|
| Revenue Growth (YoY) | 37.13% | 82.74% | 158.53% | 208.83% | 18.03% | Upgrade
|
| Cost of Revenue | 242.69 | 179.46 | 87.53 | 28.19 | 9.1 | Upgrade
|
| Gross Profit | 362.81 | 262.08 | 154.09 | 65.27 | 21.16 | Upgrade
|
| Selling, General & Admin | 185.17 | 168.62 | 119.55 | 69.9 | 38.28 | Upgrade
|
| Research & Development | 69.06 | 55.97 | 36.06 | 26.81 | 22.3 | Upgrade
|
| Operating Expenses | 254.22 | 224.59 | 155.61 | 96.71 | 60.59 | Upgrade
|
| Operating Income | 108.58 | 37.5 | -1.52 | -31.44 | -39.43 | Upgrade
|
| Interest Expense | -13.78 | -14.41 | -10.79 | -3.73 | -3.87 | Upgrade
|
| Interest & Investment Income | 11.4 | 13.4 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1 | 0.7 | - | - | -1 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.32 | -1.41 | 12.85 | -0.43 | 0.12 | Upgrade
|
| EBT Excluding Unusual Items | 107.52 | 35.78 | 0.54 | -35.59 | -44.18 | Upgrade
|
| Other Unusual Items | - | - | - | -0.58 | - | Upgrade
|
| Pretax Income | 107.52 | 35.78 | -26.67 | -36.17 | -44.18 | Upgrade
|
| Income Tax Expense | -82.77 | 0.32 | -1.64 | 0.07 | 0.04 | Upgrade
|
| Net Income | 190.29 | 35.46 | -25.03 | -36.23 | -44.22 | Upgrade
|
| Net Income to Common | 190.29 | 35.46 | -25.03 | -36.23 | -44.22 | Upgrade
|
| Net Income Growth | 436.58% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 34 | 33 | 33 | 30 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 35 | 33 | 30 | 28 | Upgrade
|
| Shares Change (YoY) | 15.12% | 8.30% | 10.02% | 7.02% | 11.80% | Upgrade
|
| EPS (Basic) | 5.60 | 1.07 | -0.77 | -1.23 | -1.60 | Upgrade
|
| EPS (Diluted) | 4.87 | 1.01 | -0.77 | -1.23 | -1.60 | Upgrade
|
| EPS Growth | 382.53% | - | - | - | - | Upgrade
|
| Free Cash Flow | 133.59 | -80.94 | -164.88 | -57.72 | -32.38 | Upgrade
|
| Free Cash Flow Per Share | 3.29 | -2.30 | -5.07 | -1.95 | -1.17 | Upgrade
|
| Gross Margin | 59.92% | 59.36% | 63.77% | 69.84% | 69.92% | Upgrade
|
| Operating Margin | 17.93% | 8.49% | -0.63% | -33.64% | -130.29% | Upgrade
|
| Profit Margin | 31.43% | 8.03% | -10.36% | -38.77% | -146.11% | Upgrade
|
| Free Cash Flow Margin | 22.06% | -18.33% | -68.24% | -61.76% | -107.01% | Upgrade
|
| EBITDA | 134.47 | 57.25 | 6.66 | -27.96 | -37.61 | Upgrade
|
| EBITDA Margin | 22.21% | 12.97% | 2.76% | -29.92% | -124.28% | Upgrade
|
| D&A For EBITDA | 25.89 | 19.76 | 8.18 | 3.48 | 1.82 | Upgrade
|
| EBIT | 108.58 | 37.5 | -1.52 | -31.44 | -39.43 | Upgrade
|
| EBIT Margin | 17.93% | 8.49% | -0.63% | -33.64% | -130.29% | Upgrade
|
| Effective Tax Rate | - | 0.88% | - | - | - | Upgrade
|
| Revenue as Reported | 605.49 | 441.54 | 241.62 | 93.46 | 30.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.